Expanded Access for Repotrectinib
NCT05926232 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2023-07-03
Summary
This is an expanded access designed to provide access to Repotrectinib for eligible participants.
Interventions
- DRUG
-
Repotrectinib
Repotrectinib
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Coronary Vasomotor Response After Riociguat Exposure
NCT01165931 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
NCT06295679 ·Status: RECRUITING
-
Albiglutide Thorough ECG Study in Healthy Volunteers
NCT01406262 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
NCT05009862 ·Status: COMPLETED ·Phase: PHASE4
-
Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease
NCT03743636 ·Status: COMPLETED ·Phase: PHASE3
-
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
NCT00733174 ·Status: UNKNOWN ·Phase: PHASE4
-
Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis
NCT01666704 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Evacetrapib in High-Risk Vascular Disease
NCT01687998 ·Status: TERMINATED ·Phase: PHASE3
-
Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
NCT00995930 ·Status: COMPLETED ·Phase: PHASE2
-
Rosiglitazone Versus Placebo in Chronic Stable Angina
NCT00225355 ·Status: TERMINATED ·Phase: PHASE4
-
Revacept in Symptomatic Carotid Stenosis
NCT01645306 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease
NCT01058018 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronate In the Prevention of Paget's Disease: Long Term Extension
NCT03859895 ·Status: ENROLLING_BY_INVITATION
-
Integrating Pharmacogenetics In Clinical Care
NCT02871934 ·Status: COMPLETED ·Phase: NA
-
Effects of Rivaroxaban on Vascular FMD in Patients With Stable Atherosclerotic Vascular Diseases
NCT06986369 ·Status: COMPLETED ·Phase: PHASE4
-
An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
NCT00695305 ·Status: COMPLETED ·Phase: PHASE2
-
Pelacarsen Roll-over Extension Program
NCT06875973 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
NCT00185042 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease
NCT03829046 ·Status: COMPLETED ·Phase: PHASE4
-
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
NCT05711719 ·Status: COMPLETED ·Phase: PHASE2
-
Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody
NCT04141579 ·Status: COMPLETED ·Phase: NA
-
A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)
NCT00320502 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina
NCT00185263 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction
NCT04610892 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects
NCT03162900 ·Status: COMPLETED ·Phase: PHASE1